Product Code: GVR-4-68039-996-4
DNA Methylation Market Growth & Trends:
The global DNA methylation market size is expected to reach USD 4.22 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increased usage of DNA methylation in sequencing analysis. The increased adoption of DNA methylation in the agrigenomics field remains a promising driver of this growth.
In January 2020, a research journal published in Springer stated that DNA methylation and expression analysis shows peanut foliar disease resistance genes have epialleles. DNA methylation analysis continues to open new doors of opportunities for researchers, and pharmaceutical companies. Increased research and developments in this field would further drive the DNA methylation industry in the coming years.
Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to the overall growth. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were undiagnosed in the U.S. The chronic disease. resulted in 16,410 deaths.
Growing esophageal cancer cases in the U.S. highlight the urgent need for early intervention measures that can help improve the low survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers could be used for the detection of esophageal adenocarcinoma and high-grade dysplasia.
The significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that theepigenetics-based treatment strategies are to be used for studying Alzheimer's disease. However, a lack of expertise to perform DNA methylation experiments could restrict the growth. DNA methylation holds significant potential in various biotechnology applications, while the relatively low number of skilled professionals remains an obstacle to growth.
Key players operating in the market are taking several initiatives such as new product developments, entering into a strategic alliance, and regional expansion among others. For instance, in May 2022, Oxford Nanopore announced integrating Remora, a technique that offers accurate and real-time epigenetic insights with nanopore sequencing software. This would further offer simple access to accurate whole genome methylation detection. Similarly, in June 2020, Base Genomics announced of advancing and developing its DNA methylation technology. the aim is to sequence a large amount of epigenetic data from a blood test which could revolutionize the preventative medicine arena.
DNA Methylation Market Report Highlights:
- The overall growth is attributed to the growing adoption of DNA methylation in sequencing analysis in the molecular biology and genomics and agrigenomics fields
- By technology, the sequencing segment captured the highest share in 2021, owing to the increasing adoption of sequencing technology for research purposes by numerous market players
- By product, the consumables segment dominated the market as it is majorly used in the DNA sequencing procedures and diagnosis process
- By application, the clinical research segment dominated the market due to the rising number of clinical trials for various diseases globally, and constant government support leading to increasing R&D expenditure
- By end use, pharmaceutical and biotechnology companies dominated the market, thanks to the increasing usage of high throughput technologies such as NGS by key market players
- North America dominated the market in 2021 due to the wide network of manufacturing and R&D facilities. The growing number of product launches, FDA approvals, and the presence of key market players remains a promising driver of growth in this region
Table of Contents
Chapter 1 DNA Methylation Market: Methodology And Scope
- 1.1 Market Segmentation
- 1.1.1 Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
- 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Regional Market: CAGR Calculation
- 1.9 List Of Secondary Sources
- 1.10 Objectives
- 1.10.1 Objective 1:
- 1.10.2 Objective 2:
- 1.11 List of Abbreviations
Chapter 2 DNA Methylation Market: Executive Summary
- 2.1 DNA Methylation Market: Market Outlook
Chapter 3 DNA Methylation Market: Industry Outlook
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Lineage Outlook
- 3.1.2 Related/Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Market Dynamics
- 3.3.1 Market Drivers
- 3.3.1.1 Increasing adoption of DNA methylation technology in oncology research
- 3.3.1.2 Growing prevalence of cancer globally
- 3.3.1.3 Increasing adoption of DNA methylation as epigenetic biomarkers
- 3.3.2 Market restraint Analysis
- 3.3.2.1 Lack of expertise and biotechnological knowledge to conduct DNA methylation experiments
- 3.3.2.2 Less adoption of DNA methylation as a commercial diagnostic test
- 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- 3.5 Industry Analysis - Porter's
- 3.6 Reimbursement & Regulatory Scenario
- 3.7 Major Deals & Strategic Alliances
- 3.7.1 New Product Launch
- 3.7.2 Acquisition
- 3.7.3 Expansion
- 3.7.4 Partnerships
- 3.7.5 Marketing & Promotions
Chapter 4 DNA Methylation Market: Competitive Landscape
- 4.1 Recent Developments & Impact Analysis, By Key Market Participants
- 4.2 Company Categorization
- 4.2.1 Innovators
- 4.2.1.1 Market Differentiators
- 4.3 Vendor Landscape
- 4.3.1 List Of Key Distributors And Channel Partners
- 4.3.2 Key Customers
- 4.3.3 Key Company Market Share Analysis, 2021
- 4.4 Public Companies
- 4.4.1 Competitive Dashboard Analysis
- 4.5 Private Companies
- 4.5.1 List Of Key Emerging Companies
- 4.6 Regional Network Map
Chapter 5 DNA Methylation Market: Technology Business Analysis
- 5.1 DNA Methylation Market: Technology Movement Analysis
- 5.2 Polymerase Chain Reaction (PCR)
- 5.2.1 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3 Microarray
- 5.3.1 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4 Sequencing
- 5.4.1 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 DNA Methylation Market: Product Business Analysis
- 6.1 DNA Methylation Market: Product Movement Analysis
- 6.2 Consumables
- 6.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3 Kits & Reagents
- 6.3.1 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4 Enzymes
- 6.4.1 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5 Instruments & Software
- 6.5.1 Instruments & software market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 DNA Methylation Market: Application Business Analysis
- 7.1 DNA Methylation Market: Application Movement Analysis
- 7.2 Gene therapy
- 7.2.1 Gene therapy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3 Clinical Research
- 7.3.1 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4 Diagnostics
- 7.4.1 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 DNA Methylation Market: End-use Business Analysis
- 8.1 DNA Methylation Market: End-use Movement Analysis
- 8.2 Hospital & Diagnostic Laboratories
- 8.2.1 Hospital & diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3 Pharmaceutical & Biotechnology Companies
- 8.3.1 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
- 8.4 Research & Academia
- 8.4.1 Research & academia market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 DNA Methylation Market: Regional Business Analysis
- 9.1 Market Share Analysis by Country, 2021 & 2030
- 9.1.1 North America
- 9.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.1.2 U.S.
- 9.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.1.3 Canada
- 9.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2 Europe
- 9.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2.2 U.K.
- 9.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2.3 Germany
- 9.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2.4 France
- 9.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2.5 Italy
- 9.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.2.6 Spain
- 9.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3 Asia-Pacific
- 9.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3.2 Japan
- 9.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3.3 China
- 9.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3.4 India
- 9.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3.5 South Korea
- 9.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.3.6 Australia
- 9.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.4 Latin America
- 9.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.4.2 Brazil
- 9.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.4.3 Mexico
- 9.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.4.4 Argentina
- 9.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.5 Middle East & Africa
- 9.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.5.2 South Africa
- 9.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.5.3 Saudi Arabia
- 9.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 9.1.5.4 UAE
- 9.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10 DNA Methylation Market: Company Profiling
- 10.1 Company Profiles
- 10.1.1 New England Biolabs
- 10.1.1.1 Company overview
- 10.1.1.2 Financial performance
- 10.1.1.3 Product benchmarking
- 10.1.1.4 Strategic initiatives
- 10.1.2 Sysmex Corporation
- 10.1.2.1 Company overview
- 10.1.2.2 Financial performance
- 10.1.2.3 Product benchmarking
- 10.1.2.4 Strategic initiatives
- 10.1.3 Abcam plc.
- 10.1.3.1 Company overview
- 10.1.3.2 Financial performance
- 10.1.3.3 Product benchmarking
- 10.1.3.4 Strategic initiatives
- 10.1.4 F. Hoffmann-La Roche Ltd.
- 10.1.4.1 Company overview
- 10.1.4.2 Financial performance
- 10.1.4.3 Product benchmarking
- 10.1.4.4 Strategic initiatives
- 10.1.5 Diagenode Diagnostics S.A.
- 10.1.5.1 Company overview
- 10.1.5.2 Financial performance
- 10.1.5.3 Product benchmarking
- 10.1.5.4 Strategic initiatives
- 10.1.6 Thermo-Fisher Scientific Inc.
- 10.1.6.1 Company overview
- 10.1.6.2 Financial performance
- 10.1.6.3 Product benchmarking
- 10.1.6.4 Strategic initiatives
- 10.1.7 Agilent Technologies Inc.
- 10.1.7.1 Company overview
- 10.1.7.2 Financial performance
- 10.1.7.3 Product benchmarking
- 10.1.7.4 Strategic initiatives
- 10.1.8 BioRad Laboratories Inc.
- 10.1.8.1 Company overview
- 10.1.8.2 Financial performance
- 10.1.8.3 Product benchmarking
- 10.1.8.4 Strategic initiatives
- 10.1.9 Exact Sciences Corporation
- 10.1.9.1 Company overview
- 10.1.9.2 Financial performance
- 10.1.9.3 Product benchmarking
- 10.1.9.4 Strategic initiatives
- 10.1.10 QIAGEN N.V.
- 10.1.10.1 Company overview
- 10.1.10.2 Financial performance
- 10.1.10.3 Product benchmarking
- 10.1.10.4 Strategic initiatives
- 10.1.11 QIAGEN N.V.
- 10.1.11.1 Company overview
- 10.1.11.2 Financial performance
- 10.1.11.3 Product benchmarking
- 10.1.11.4 Strategic initiatives
- 10.1.12 Active Motif, Inc.
- 10.1.12.1 Company overview
- 10.1.12.2 Financial performance
- 10.1.12.3 Product benchmarking
- 10.1.12.4 Strategic initiatives
- 10.1.13 Illumina Inc.
- 10.1.13.1 Company overview
- 10.1.13.2 Financial performance
- 10.1.13.3 Product benchmarking
- 10.1.13.4 Strategic initiatives
- 10.1.14 EpiGentek Group Inc.
- 10.1.14.1 Company overview
- 10.1.14.2 Financial performance
- 10.1.14.3 Product benchmarking
- 10.1.14.4 Strategic initiatives
- 10.1.15 Pacific Biosciences Inc.
- 10.1.15.1 Company overview
- 10.1.15.2 Financial performance
- 10.1.15.3 Product benchmarking
- 10.1.15.4 Strategic initiatives
- 10.1.16 New England Biolabs Inc.
- 10.1.16.1 Company overview
- 10.1.16.2 Financial performance
- 10.1.16.3 Product benchmarking
- 10.1.16.4 Strategic initiatives
- 10.1.17 Merck KGaA
- 10.1.17.1 Company overview
- 10.1.17.2 Financial performance
- 10.1.17.3 Product benchmarking
- 10.1.17.4 Strategic initiatives
- 10.1.19 Zymo Research Corporation
- 10.1.18.1 Company overview
- 10.1.18.2 Financial performance
- 10.1.18.3 Product benchmarking
- 10.1.18.4 Strategic initiatives
- 10.1.19 PerkinElmer Inc.
- 10.1.19.1 Company overview
- 10.1.19.2 Financial performance
- 10.1.19.3 Product benchmarking
- 10.1.19.4 Strategic initiatives
- 10.2 List of Other Key Players